The impact of molecular morphology techniques on the expert diagnosis in melanocytic skin neoplasms

International Journal of Surgical Pathology

Volumn 21, Issue 5, 2013, Pages 483-492

  Ferrara, Gerardo ^a   Misciali, Cosimo ^b   Brenn, Thomas ^c   Cerroni, Lorenzo ^d   Kazakov, Dmitry W ^e   Perasole, Antonio ^f   Russo, Rosa ^g   Ricci, Roberto ^h   Crisman, Giuliana ⁱ   Fanti, Pier Alessandro ^b   Passarini, Beatrice ^b   Patrizi, Annalisa ^b  

^a G RUMMO HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e CHARLES UNIVERSITY   (Czech Republic)

^f Department of Medical Oncology   (Italy)

^g UNIVERSITY HOSPITAL SAN GIOVANNI DI DIO E RUGGI D ARAGONA   (Italy)

^h UNIVERSITY OF PARMA   (Italy)

ⁱ UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

atypical nevus; fluorescence in situ hybridization; immunohistochemistry; melanoma

Indexed keywords

CYCLIN D1; GLYCOPROTEIN GP 100; KI 67 ANTIGEN; MONOCLONAL ANTIBODY HMB 45; PROTEIN MYB; PROTEIN P16; UVOMORULIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CENTROMERE; CHROMOSOME 11Q; CHROMOSOME 6Q; CLINICAL ARTICLE; CONGENITAL NEVUS; CONSULTATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JUVENILE MELANOMA; MALE; MELANOMA; PRIORITY JOURNAL;

ATYPICAL NEVUS; FLUORESCENCE IN SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; MELANOMA;

ADULT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MELANOMA; MIDDLE AGED; NEVUS, PIGMENTED; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884687743     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896913491323     Document Type: Article

References (40)

1. Crotty K, McCarthy SW, Mihm MC Textbook of Melanoma: Pathology, Diagnosis and Management. Thompson JF Morton DL Kroon BB, ed. London, UK: Martin-Dunitz ; 2004: 115-121.
2. Elder D Lever's Histopathology of the Skin. 10 th ed.Philadelphia, PA: Lippincott Williams & Wilkins; 2008:699-789. Elder D, ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 2008: 699-789.
3. Zalaudek I, Ferrara G, Argenziano G, Ruocco V, Soyer HP. Diagnosis and treatment of cutaneous melanoma: a practical guide. Skinmed. 2003 ; 2: 20-31
4. Elder DE, Xu X. The approach to the patient with a difficult melanocytic lesion. Pathology. 2004 ; 36: 428-434
5. Ferrara G, Tomasini C, Argenziano G, Zalaudek I, Stefanato CM. Small-diameter melanoma: toward a conceptual and practical reappraisal. J Cutan Pathol. 2012 ; 39: 721-723
6. Prieto VG, Shea CR. Use of immunohistochemistry in melanocytic lesions. J Cutan Pathol. 2008 ; 35: 1-10
7. Wasserman J, Maddox J, Racz M, Petronic-Rosic V. Update on immunohistochemical methods relevant to dermatopathology. Arch Pathol Lab Med. 2009 ; 133: 1053-1061
8. Dohse L, Ferringer T. Nodal blue nevus: a pitfall in lymph node biopsies. J Cutan Pathol. 2010 ; 37: 102-104
9. Chorny JA, Barr RJ, Kystoobayeva A, Jakowatz J, Reed RJ. Ki-67 and p53 expression in minimal deviation melanoma as compared with other nevomelanocytic lesions. Mod Pathol. 2003 ; 16: 525-529
10. Rieger E, Hoffman-Wellenhof R, Soyer HP, et al. Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki67 monoclonal antibodies in melanocytic skin lesion. J Cutan Pathol. 1993 ; 20: 229-236
11. Vogt T, Zipperer KH, Vogt A, Holzel D, Landthaler M, Stolz W. p53 and Ki-67 antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin. Histopathology. 1997 ; 30: 57-63
12. Korabiowska M, Brinck U, Middel P, et al. Proliferative activity in the progression of pigmented skin lesions, diagnostic and prognostic significance. Anticancer Res. 2000 ; 20: 1781-1785
13. Li LX, Crotty KA, McCarthy SW, Palmer AA, Krill JJ. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol. 2000 ; 22: 489-495
14. George E, Polissar NL, Wick M. Immunohistochemical evaluation of 16INK4A, E-cadherin, and cyclin D1 expression in melanoma and Spitz tumors. Am J Clin Pathol. 2010 ; 133: 370-379
15. Tran TA, Ross JS, Carlson JA, Mihm MC. Mitotic cyclins and cyclin dependent kinases in melanocytic lesions. Hum Pathol. 1998 ; 29: 1085-1090
16. Georgieva J, Sinha P, Schadendorf D. Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions. J Clin Pathol. 2001 ; 54: 229-235
17. Stefanaki C, Stefanaki K, Antoniou C, et al. G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas. J Cutan Pathol. 2008 ; 35: 799-808
18. Alekseenko A, Wojas-Pelc A, Lis GJ, Furgal-Borzych A, Surowka G, Litwin JA. Cyclin D1 and D3 expression in melanocytic skin lesions. Arch Dermatol Res. 2010 ; 302: 545-550
19. Garrido-Ruiz MC, Requena L, Ortiz P, Perez-Gomez B, Alonso SR, Rodriguez-Peralto JL. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study. Mod Pathol. 2010 ; 23: 1215-1224
20. Carlson JA, Ross JS, Slominski AJ. New techniques in dermatopathology that help to diagnose and prognosticate melanoma. Clin Dermatol. 2009 ; 27: 75-102
21. Sparrow LE, Eldon MJ, English DR, Heenan PJ. p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry. Am J Dermatopathol. 1998 ; 20: 255-261
22. Al Dhaybi R, Agoumi M, Gagné I, McCuaig C, Powell J, Kokta V. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi. J Am Acad Dermatol. 2011 ; 65: 357-363
23. Hilliard NJ, Krahl D, Sellheyer K. p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma. J Cutan Pathol. 2009 ; 36: 753-759
24. Mason A, Wititsuwannakul J, Klump VR, Lott J, Lazova R. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma. J Cutan Pathol. 2012 ; 39: 1062-1074
25. Gerami P, Mafee M, Lurtsbarapa T, Guitart J, Haghighat Z, Newman M. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. Arch Dermatol. 2010 ; 146: 273-278
26. Udart M, Utikal J, Krähn GM, Peter RU. Chromosome 7 aneusomy. A marker for metastatic melanoma?. Neoplasia. 2001 ; 3: 245-254
27. Fabrizi G, Pennacchia I, Pagliarello C, Massi G. Sclerosing nevus with pseudomelanomatous features. J Cutan Pathol. 2008 ; 35: 995-1002
28. Ferrara G, Amantea A, Argenziano G, et al. Sclerosing nevus with pseudomelanomatous features and regressing melanoma with nevoid features. J Cutan Pathol. 2009 ; 36: 913-915
29. Ko CJ, Bolognia JL, Glusac EJ. 'Clark/dysplastic' nevi with florid fibroplasia associated with pseudomelanomatous features. J Am Acad Dermatol. 2011 ; 64: 346-351
30. Wititsuwannakul J, Mason AR, Klump VR, Lazova R. Neuropilin-2 as a useful marker in the differentiation between Spitzoid malignant melanoma and Spitz nevus. J Am Acad Dermatol. 2013 ; 68: 129-137
31. Roukos DH. Novel clinic-genome modelling for revolutionizing genotype-phenotype based personalized cancer care. Expert Rev Mol Diagn. 2010 ; 10: 33-48
32. Massi D, Cesinaro AM, Tomasini C, et al. Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. J Am Acad Dermatol. 2011 ; 64: 919-935
33. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathologic features. Am J Pathol. 2000 ; 157: 967-972
34. Martin V, Banfi S, Bordoni A, Leoni-Parvex S, Mazzucchelli L. Presence of cytogenetic abnormalities in Spitz nevi: a diagnostic challenge for fluorescence in situ hybridization analysis. Histopathology. 2011 ; 60: 336-346
35. Isaac AK, Lertsburapa T, Pathria Mundi J, Martini M, Guitart J, Gerami P. Polyploidy in Spitz nevi: a not uncommon kariotypic abnormality identifiable by fluorescence in-situ hybridization. Am J Dermatopathol. 2010 ; 32: 144-148
36. Gammon B, Beilfuss B, Guitart J, Gerami P. Enhanced detection of Spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe. Am J Surg Pathol. 2012 ; 36: 81-88
37. Gerami P, Wass A, Mafee M, Fang Y, Pulitzer MP, Busam KJ. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Am J Surg Pathol. 2009 ; 33: 1783-1788
38. Gerami P, Li G, Pouryazdanparast P, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol. 2012 ; 36: 808-817
39. Raskin L, Ludgate M, Iyer RK, et al. Copy number variations and clinical outcome in atypical Spitz tumors. Am J Surg Pathol. 2011 ; 35: 243-252
40. van Dijk MC, Bernsen MR, Ruiter DJ. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. Am J Surg Pathol. 2005 ; 29: 1145-1151